Geoffrey R. Weiss

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Karen Kelly, John Crowley, Paul A. Bunn et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Medicine, Oncology, Pharmacology +17

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

David F. McDermott, Meredith M. Regan, Joseph I. Clark et al. · Journal of Clinical Oncology · 2004 · 819 citations

Medicine, Oncology, Pharmacotherapy +15

A Southwest Oncology Group study

Terry R. Jenkins, Catherine M. Tangen, John S. Macdonald et al. · 1993 · 775 citations

Medicine, Oncology, Pharmacology +12

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 616 citations

Medicine, Oncology, Medical Oncology +14

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.

Agnieszka Woźniak, John J. Crowley, S P Balcerzak et al. · Journal of Clinical Oncology · 1998 · 567 citations

Medicine, Oncology, Pharmacology +11